Noramco™
Mathew Minardi is currently serving as the Executive Vice President and Site Leader at Sterling Pharma Solutions since April 2019. Prior to this, Mathew held various roles at Noramco, Inc. from August 2006 onwards, including Vice President of Sales, Site General Manager, and Vice President of R&D. Additionally, Mathew worked as the VP Technical Services at Accord Healthcare from November 2017 to April 2019. With a background in Synthetic Chemistry, Mathew has demonstrated strong leadership skills, revenue performance, and strategic insights across various roles in the pharmaceutical industry.
This person is not in any offices
Noramco™
Noramco, headquartered in Wilmington, Delaware, is a global leader in the production of controlled substances for the pharmaceutical industry, for medicines used to treat attention deficit hyperactivity disorder, pain, addiction, and for abuse-deterrent formulations. We realize our success through a keen focus on commercial and operational excellence as well as continuing strategic growth. Our global footprint includes Athens, GA, Wilmington, DE and Neuhausen, Switzerland. Specialists in controlled substance development and manufacturing, Noramco is a partner to the pharmaceutical industry: – Focusing on high-purity controlled substances – Leveraging intellectual property to devise the most efficient routes to APIs – Providing analytical data, chemical and physical properties, stability studies and regulatory assistance – Formulation friendly particle size grades and extended technical packages – Delivering DEA-compliant security and production capacity, from kilos to multi-ton supply – Supporting world-class supply security of controlled-substances, from schedule I to schedule III